Q2 2025 Arcticzymes Technologies ASA Earnings Call Transcript
Key Points
- ArcticZymes Technologies ASA (LTS:0DRV) reported a 5% increase in total revenues, reaching almost $29 million.
- The company's EBITDA increased by 50% to nearly NOK4 million, indicating improved profitability.
- The bio manufacturing business experienced significant growth, with revenues reaching $18.1 million, a 50% year-over-year increase.
- The launch of the M-SAN HQ GMP product in mid-June was successful, becoming the most sold product in Q2 with a 62% growth compared to the previous year.
- The company has a diversified customer base, reducing dependency on any single customer and enhancing revenue stability.
- The molecular tools segment experienced a 40% decline in revenues year-over-year due to the absence of orders from a key customer.
- There was a 10% decline in total unique customers, primarily driven by a 20% drop in molecular tools customers.
- The company faced a NOK0.7 million loss related to trade receivables, marking the first significant loss in this area.
- Currency fluctuations negatively impacted the company's financials, with a NOK0.5 million decrease in the second quarter.
- Sales in the first six months of the year decreased by 12% compared to the same period last year, highlighting challenges in maintaining growth momentum.
Sorry about that. So I'm going to recap the highlights if everything was not audible.
We had a strong quarter. The total revenues were up 5% to almost $29 million. We saw the effects of our customer centric strategy. We also saw a positive EBITDA. It was up 50% to almost NOK4 million . One of our flag flagship products was launched M-SAN HQ GMP mid June, and we expect a lot from this product going forward. M-SAN HQ was the most sold product in Q2 with a growth of 62% versus last year.
The big star of the show in the quarter was the bio manufacturing business. We saw Growth accelerates up to $18.1 million for the quarter. Which was a 50% increase year or year. I hope that you're able to see the slides. I believe that we've had some technical issues unfortunately during the first part of this presentation. I apologize, but now it is supposed to work.
But by manufacturing, surpassed our expectations for the quarter and we had a lot of customers. It was a diversified customer base that ordered within, the segment
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
